MPL and hematopoietic and lymphoid system neoplasm: Myeloproliferation, the shared hallmark of these hematologic neoplasms, is sustained by the constitutive activation of the JAK/STAT signaling pathway downstream of hematopoietic growth factor receptors, primarily EPO-R and TPO-R.